{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T02:16:52Z","timestamp":1785291412177,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971586"],"award-info":[{"award-number":["81971586"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771887"],"award-info":[{"award-number":["81771887"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"1\u00b73\u00b75 project for dis- ciplines of excellence, West China Hospital, Sichuan University","award":["ZYGD18013"],"award-info":[{"award-number":["ZYGD18013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Previous researches on large animal models of diabetic cardiomyopathy were insufficient. The aim of this study was to evaluate early changes in left ventricular (LV) function and morphology in diabetic pigs using a cardiac magnetic resonance (CMR) time-volume curve and feature tracking technique.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Streptozotocin (STZ) was used to induce diabetic in sixteen pigs. 3.0T MRI scanned the pig\u2019s heart before and 2, 6, 10 and 16 months after modelling. CMR biomarkers, including time-volume curve and myocardial strain, were compared to analyse the longitudinal changes in LV function and morphology. Pearson correlation was used to evaluate the relationship between LV strain and remodelling. Cardiac specimens were obtained at 6, 10, and 16 months after modelling to observe the myocardial ultrastructural and microstructure at different courses of diabetes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Twelve pigs developed diabetes. The 80% diastolic volume recovery rate (DVR) at 6 months after modelling was significantly higher than that before modelling (0.78\u2009\u00b1\u20090.08vs. 0.67\u2009\u00b1\u20090.15). The LV global longitudinal peak strain (GLPS) (\u2212\u00a010.21\u2009\u00b1\u20093.15 vs. \u2212\u00a09.74\u2009\u00b1\u20092.78 vs. \u2212\u00a09.38\u2009\u00b1\u20093.71 vs. \u2212\u00a08.71\u2009\u00b1\u20092.68 vs. \u2212\u00a06.59\u2009\u00b1\u20092.90%) altered gradually from the baseline data to 2, 6, 10 and 16 months after modelling. After 16 months of modelling, the LV remodelling index (LVRI) of pigs increased compared with that before modelling (2.19\u2009\u00b1\u20090.97 vs. 1.36\u2009\u00b1\u20090.45\u00a0g\/ml). The LVRI and myocardial peak strain were correlated in diabetic pigs (r= \u2212\u00a00.40 to \u2212\u00a00.54), with GLPS being the most significant. Electron microscopy and Masson staining showed that myocardial damage and fibrosis gradually increased with the progression of the disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Intravenous injection of STZ can induce a porcine diabetic cardiomyopathy model, mainly characterized by decreased LV diastolic function and strain changes accompanied by myocardial remodelling. The changes in CMR biomarkers could reflect the early myocardial injury of diabetic cardiomyopathy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12933-022-01734-y","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T10:05:14Z","timestamp":1673345114000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Early longitudinal changes in left ventricular function and morphology in diabetic pigs: evaluation by 3.0T magnetic resonance imaging"],"prefix":"10.1186","volume":"22","author":[{"given":"Wei-Feng","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Kun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ting","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Yan","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Gang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,10]]},"reference":[{"issue":"10027","key":"1734_CR1","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/s0140-6736(16)00618-8","volume":"387","author":"B Zhou","year":"2016","unstructured":"Zhou B, Lu Y, Hajifathalian K, Bentham J, Di Cesare M, Danaei G, et al. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4\u00b74 million participants. The Lancet. 2016;387(10027):1513\u201330. https:\/\/doi.org\/10.1016\/s0140-6736(16)00618-8.","journal-title":"The Lancet"},{"key":"1734_CR2","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"P Saeedi","year":"2019","unstructured":"Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. 2019;157:107843. https:\/\/doi.org\/10.1016\/j.diabres.2019.107843.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"1734_CR3","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12933-021-01408-1","volume":"20","author":"A Ceriello","year":"2021","unstructured":"Ceriello A, Catrinoiu D, Chandramouli C, Cosentino F, Dombrowsky A, Itzhak B, et al. Heart failure in type 2 diabetes: current perspectives on screening, diagnosis and management. Cardiovasc Diabetol. 2021;20(1):218. https:\/\/doi.org\/10.1186\/s12933-021-01408-1.","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"1734_CR4","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1161\/circresaha.118.314665","volume":"124","author":"W Dillmann","year":"2019","unstructured":"Dillmann W, Diabetic, Cardiomyopathy. Circul Res. 2019;124(8):1160\u20132. https:\/\/doi.org\/10.1161\/circresaha.118.314665.","journal-title":"Circul Res"},{"issue":"12","key":"1734_CR5","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.jcmg.2015.11.001","volume":"8","author":"P Claus","year":"2015","unstructured":"Claus P, Omar A, Pedrizzetti G, Sengupta P, Nagel E. Tissue tracking technology for assessing cardiac mechanics: principles, normal values, and clinical applications. JACC Cardiovasc imaging. 2015;8(12):1444\u201360. https:\/\/doi.org\/10.1016\/j.jcmg.2015.11.001.","journal-title":"JACC Cardiovasc imaging"},{"key":"1734_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1532-429x-12-46","volume":"12","author":"D Mendoza","year":"2010","unstructured":"Mendoza D, Codella N, Wang Y, Prince M, Sethi S, Manoushagian S, et al. Impact of diastolic dysfunction severity on global left ventricular volumetric filling\u2014assessment by automated segmentation of routine cine cardiovascular magnetic resonance. J Cardiovasc Magn resonance: official J Soc Cardiovasc Magn Reson. 2010;12:46. https:\/\/doi.org\/10.1186\/1532-429x-12-46.","journal-title":"J Cardiovasc Magn resonance: official J Soc Cardiovasc Magn Reson"},{"issue":"1","key":"1734_CR7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12872-017-0583-5","volume":"17","author":"H Xu","year":"2017","unstructured":"Xu H, Yang Z, Guo Y, Shi K, Liu X, Zhang Q, et al. Volume-time curve of cardiac magnetic resonance assessed left ventricular dysfunction in coronary artery disease patients with type 2 diabetes mellitus. BMC Cardiovasc Disord. 2017;17(1):145. https:\/\/doi.org\/10.1186\/s12872-017-0583-5.","journal-title":"BMC Cardiovasc Disord"},{"issue":"9","key":"1734_CR8","doi-asserted-by":"publisher","first-page":"e002188","DOI":"10.1161\/jaha.115.002188","volume":"4","author":"C Tsao","year":"2015","unstructured":"Tsao C, Gona P, Salton C, Chuang M, Levy D, Manning W, et al. Left ventricular structure and risk of Cardiovascular events: a Framingham Heart Study Cardiac magnetic resonance study. J Am Heart Association. 2015;4(9):e002188. https:\/\/doi.org\/10.1161\/jaha.115.002188.","journal-title":"J Am Heart Association"},{"issue":"4","key":"1734_CR9","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/circresaha.117.311586","volume":"122","author":"G Jia","year":"2018","unstructured":"Jia G, Hill M, Sowers J. Diabetic Cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circul Res. 2018;122(4):624\u201338. https:\/\/doi.org\/10.1161\/circresaha.117.311586.","journal-title":"Circul Res"},{"issue":"1","key":"1734_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00395-018-0711-0","volume":"114","author":"C Riehle","year":"2018","unstructured":"Riehle C, Bauersachs J. Of mice and men: models and mechanisms of diabetic cardiomyopathy. Basic Res Cardiol. 2018;114(1):2. https:\/\/doi.org\/10.1007\/s00395-018-0711-0.","journal-title":"Basic Res Cardiol"},{"issue":"2","key":"1734_CR11","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00441-019-03158-9","volume":"380","author":"S Renner","year":"2020","unstructured":"Renner S, Blutke A, Clauss S, Deeg CA, Kemter E, Merkus D, et al. Porcine models for studying complications and organ crosstalk in diabetes mellitus. Cell Tissue Res. 2020;380(2):341\u201378. https:\/\/doi.org\/10.1007\/s00441-019-03158-9.","journal-title":"Cell Tissue Res"},{"issue":"1","key":"1734_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12968-020-00610-6","volume":"22","author":"J Schulz-Menger","year":"2020","unstructured":"Schulz-Menger J, Bluemke D, Bremerich J, Flamm S, Fogel M, Friedrich M, et al. Standardized image interpretation and post-processing in cardiovascular magnetic resonance\u20142020 update: Society for Cardiovascular magnetic resonance (SCMR): Board of Trustees Task Force on standardized post-processing. J Cardiovasc Magn resonance: official J Soc Cardiovasc Magn Reson. 2020;22(1):19. https:\/\/doi.org\/10.1186\/s12968-020-00610-6.","journal-title":"J Cardiovasc Magn resonance: official J Soc Cardiovasc Magn Reson"},{"issue":"2","key":"1734_CR13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1136\/hrt.2006.093997","volume":"93","author":"S De Castro","year":"2007","unstructured":"De Castro S, Caselli S, Maron M, Pelliccia A, Cavarretta E, Maddukuri P, et al. Left ventricular remodelling index (LVRI) in various pathophysiological conditions: a real-time three-dimensional echocardiographic study. Heart. 2007;93(2):205\u20139. https:\/\/doi.org\/10.1136\/hrt.2006.093997.","journal-title":"Heart"},{"issue":"6","key":"1734_CR14","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1161\/circimaging.109.879304","volume":"2","author":"K Kawaji","year":"2009","unstructured":"Kawaji K, Codella N, Prince M, Chu C, Shakoor A, LaBounty T, et al. Automated segmentation of routine clinical cardiac magnetic resonance imaging for assessment of left ventricular diastolic dysfunction. Circulation Cardiovasc imaging. 2009;2(6):476\u201384. https:\/\/doi.org\/10.1161\/circimaging.109.879304.","journal-title":"Circulation Cardiovasc imaging"},{"issue":"2","key":"1734_CR15","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s00125-007-0886-7","volume":"51","author":"S Lenzen","year":"2008","unstructured":"Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia. 2008;51(2):216\u201326. https:\/\/doi.org\/10.1007\/s00125-007-0886-7.","journal-title":"Diabetologia"},{"issue":"1","key":"1734_CR16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/01.tp.0000189712.74495.82","volume":"81","author":"D Dufrane","year":"2006","unstructured":"Dufrane D, van Steenberghe M, Guiot Y, Goebbels RM, Saliez A, Gianello P. Streptozotocin-induced diabetes in large animals (pigs\/primates): role of GLUT2 transporter and beta-cell plasticity. Transplantation. 2006;81(1):36\u201345. https:\/\/doi.org\/10.1097\/01.tp.0000189712.74495.82.","journal-title":"Transplantation"},{"issue":"1","key":"1734_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/mpa.0b013e3181452886","volume":"36","author":"H Hara","year":"2008","unstructured":"Hara H, Lin Y, Zhu X, Tai H, Ezzelarab M, Balamurugan A, et al. Safe induction of diabetes by high-dose streptozotocin in pigs. Pancreas. 2008;36(1):31\u20138. https:\/\/doi.org\/10.1097\/mpa.0b013e3181452886.","journal-title":"Pancreas"},{"issue":"1","key":"1734_CR18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12872-022-02597-7","volume":"22","author":"G Shao","year":"2022","unstructured":"Shao G, Cao Y, Cui Y, Han X, Liu J, Li Y, et al. Multiparametric CMR imaging of myocardial structure and function changes in diabetic mini-pigs with preserved LV function: a preliminary study. BMC Cardiovasc Disord. 2022;22(1):143. https:\/\/doi.org\/10.1186\/s12872-022-02597-7.","journal-title":"BMC Cardiovasc Disord"},{"key":"1734_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvac152","author":"F Lezoualc\u2019h","year":"2022","unstructured":"Lezoualc\u2019h F, Badimon L, Baker H, Bernard M, Czibik G, de Boer R, et al. The need for adjusting experimental models to meet clinical reality. Cardiovascular Res. 2022. https:\/\/doi.org\/10.1093\/cvr\/cvac152.","journal-title":"Cardiovascular Res"},{"issue":"1","key":"1734_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12968-020-00636-w","volume":"22","author":"H Ito","year":"2020","unstructured":"Ito H, Ishida M, Makino W, Goto Y, Ichikawa Y, Kitagawa K, et al. Cardiovascular magnetic resonance feature tracking for characterization of patients with heart failure with preserved ejection fraction: correlation of global longitudinal strain with invasive diastolic functional indices. J Cardiovasc Magn resonance: official J Soc Cardiovasc Magn Reson. 2020;22(1):42. https:\/\/doi.org\/10.1186\/s12968-020-00636-w.","journal-title":"J Cardiovasc Magn resonance: official J Soc Cardiovasc Magn Reson"},{"issue":"6","key":"1734_CR21","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.jcmg.2020.10.009","volume":"14","author":"R Pofi","year":"2021","unstructured":"Pofi R, Giannetta E, Galea N, Francone M, Campolo F, Barbagallo F, et al. Diabetic cardiomiopathy progression is triggered by miR122-5p and involves extracellular matrix: a 5-year prospective study. JACC Cardiovasc imaging. 2021;14(6):1130\u201342. https:\/\/doi.org\/10.1016\/j.jcmg.2020.10.009.","journal-title":"JACC Cardiovasc imaging"},{"issue":"7","key":"1734_CR22","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1093\/eurheartj\/ehaa587","volume":"42","author":"BP Halliday","year":"2021","unstructured":"Halliday BP, Senior R, Pennell DJ. Assessing left ventricular systolic function: from ejection fraction to strain analysis. Eur Heart J. 2021;42(7):789\u201397. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa587.","journal-title":"Eur Heart J"},{"issue":"11","key":"1734_CR23","doi-asserted-by":"publisher","first-page":"1268-75 e1","DOI":"10.1016\/j.echo.2011.07.017","volume":"24","author":"L Ernande","year":"2011","unstructured":"Ernande L, Bergerot C, Rietzschel ER, De Buyzere ML, Thibault H, Pignonblanc PG, et al. Diastolic dysfunction in patients with type 2 diabetes mellitus: is it really the first marker of diabetic cardiomyopathy? J Am Soc Echocardiogr. 2011;24(11):1268-75 e1. https:\/\/doi.org\/10.1016\/j.echo.2011.07.017.","journal-title":"J Am Soc Echocardiogr"},{"issue":"6","key":"1734_CR24","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/ehjci\/jex190","volume":"19","author":"C Storz","year":"2018","unstructured":"Storz C, Hetterich H, Lorbeer R, Heber SD, Schafnitzel A, Patscheider H, et al. Myocardial tissue characterization by contrast-enhanced cardiac magnetic resonance imaging in subjects with prediabetes, diabetes, and normal controls with preserved ejection fraction from the general population. Eur Heart J Cardiovasc Imaging. 2018;19(6):701\u20138. https:\/\/doi.org\/10.1093\/ehjci\/jex190.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"9","key":"1734_CR25","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1161\/circresaha.118.314607","volume":"124","author":"M Tong","year":"2019","unstructured":"Tong M, Saito T, Zhai P, Oka S, Mizushima W, Nakamura M, et al. Mitophagy is essential for maintaining cardiac function during high Fat Diet-Induced Diabetic Cardiomyopathy. Circul Res. 2019;124(9):1360\u201371. https:\/\/doi.org\/10.1161\/circresaha.118.314607.","journal-title":"Circul Res"},{"issue":"2","key":"1734_CR26","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10741-018-9749-1","volume":"24","author":"B Parim","year":"2019","unstructured":"Parim B, Sathibabu Uddandrao V, Saravanan G. Diabetic cardiomyopathy: molecular mechanisms, detrimental effects of conventional treatment, and beneficial effects of natural therapy. Heart Fail Rev. 2019;24(2):279\u201399. https:\/\/doi.org\/10.1007\/s10741-018-9749-1.","journal-title":"Heart Fail Rev"},{"key":"1734_CR27","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.coph.2020.08.015","volume":"54","author":"S Nirengi","year":"2020","unstructured":"Nirengi S, Peres Valgas da Silva C, Stanford KI. Disruption of energy utilization in diabetic cardiomyopathy; a mini review. Curr Opin Pharmacol. 2020;54:82\u201390. https:\/\/doi.org\/10.1016\/j.coph.2020.08.015.","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"1734_CR28","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1111\/jcmm.14870","volume":"24","author":"J Luo","year":"2020","unstructured":"Luo J, Yan D, Li S, Liu S, Zeng F, Cheung C, et al. Allopurinol reduces oxidative stress and activates Nrf2\/p62 to attenuate diabetic cardiomyopathy in rats. J Cell Mol Med. 2020;24(2):1760\u201373. https:\/\/doi.org\/10.1111\/jcmm.14870.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"1734_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12933-019-0980-4","volume":"19","author":"M Arow","year":"2020","unstructured":"Arow M, Waldman M, Yadin D, Nudelman V, Shainberg A, Abraham N, et al. Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy. Cardiovasc Diabetol. 2020;19(1):7. https:\/\/doi.org\/10.1186\/s12933-019-0980-4.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"1734_CR30","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12933-021-01314-6","volume":"20","author":"L Nesti","year":"2021","unstructured":"Nesti L, Pugliese N, Sciuto P, De Biase N, Mazzola M, Fabiani I, et al. Mechanisms of reduced peak oxygen consumption in subjects with uncomplicated type 2 diabetes. Cardiovasc Diabetol. 2021;20(1):124. https:\/\/doi.org\/10.1186\/s12933-021-01314-6.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"1734_CR31","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00109-019-01861-2","volume":"98","author":"S Wang","year":"2020","unstructured":"Wang S, Zhu S, Wu J, Zhang M, Xu Y, Xu W, et al. Exercise enhances cardiac function by improving mitochondrial dysfunction and maintaining energy homoeostasis in the development of diabetic cardiomyopathy. J Mol Med. 2020;98(2):245\u201361. https:\/\/doi.org\/10.1007\/s00109-019-01861-2.","journal-title":"J Mol Med"},{"issue":"17","key":"1734_CR32","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1089\/ars.2015.6293","volume":"22","author":"CA Galloway","year":"2015","unstructured":"Galloway CA, Yoon Y. Mitochondrial dynamics in diabetic cardiomyopathy. Antioxid Redox Signal. 2015;22(17):1545\u201362. https:\/\/doi.org\/10.1089\/ars.2015.6293.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"1734_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12933-018-0767-z","volume":"17","author":"B Dai","year":"2018","unstructured":"Dai B, Li H, Fan J, Zhao Y, Yin Z, Nie X, et al. MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin. Cardiovasc Diabetol. 2018;17(1):123. https:\/\/doi.org\/10.1186\/s12933-018-0767-z.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"1734_CR34","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12933-022-01602-9","volume":"21","author":"T Cao","year":"2022","unstructured":"Cao T, Ni R, Ding W, Ji X, Li L, Liao G, et al. MLKL-mediated necroptosis is a target for cardiac protection in mouse models of type-1 diabetes. Cardiovasc Diabetol. 2022;21(1):165. https:\/\/doi.org\/10.1186\/s12933-022-01602-9.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"1734_CR35","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1900\/rds.2013.10.58","volume":"10","author":"S Hegazy","year":"2013","unstructured":"Hegazy S, Tolba O, Mostafa T, Eid M, El-Afify D. Alpha-lipoic acid improves subclinical left ventricular dysfunction in asymptomatic patients with type 1 diabetes. Rev Diabet studies: RDS. 2013;10(1):58\u201367. https:\/\/doi.org\/10.1900\/rds.2013.10.58.","journal-title":"Rev Diabet studies: RDS"},{"key":"1734_CR36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ejps.2018.02.009","volume":"117","author":"M Dworacka","year":"2018","unstructured":"Dworacka M, Chukanova G, Iskakova S, Kurmambayev Y, Weso\u0142owska A, Frycz B, et al. New arguments for beneficial effects of alpha-lipoic acid on the cardiovascular system in the course of type 2 diabetes. Eur J Pharm sciences: official J Eur Federation Pharm Sci. 2018;117:41\u20137. https:\/\/doi.org\/10.1016\/j.ejps.2018.02.009.","journal-title":"Eur J Pharm sciences: official J Eur Federation Pharm Sci"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-022-01734-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-022-01734-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-022-01734-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T16:18:10Z","timestamp":1673626690000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-022-01734-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1734"],"URL":"https:\/\/doi.org\/10.1186\/s12933-022-01734-y","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,10]]},"assertion":[{"value":"23 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Biomedical Research Ethics Committee of our hospital (2019149\u00a0A). All animal experiments complied with the ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}